Selection from HEOR Bibliography
| Search criteria | ||||
| COVID-19 |
||||
| Thrombotic and cardiovascular events and treatment patterns among patients hospitalized with COVID-19 in Japan: an analysis of a nationwide medical claims database | ||||
| Naoki Terasaka 1*, Yukako Matsuo 2, Hirohide Kataoka 2, Yasuhiko Miyata 2, Yoshio Anazawa 2 (rwesheorj A) | ||||
| 1) Medical Department, Bristol Myers Squibb K.K., Tokyo, Japan 2) Medical Department, Bristol Myers Squibb K.K., Tokyo, Japan | ||||
| Cardiology and Therapy |
||||
| , Article | ||||
| , Japan | ||||
| Abstract: https://link.springer.com/article/10.1007/s40119-022-00263-9 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, COVID-19 | 2022 | English | , Database Study | |
| COVID-19 patients analysis utilizing Japan and US claims databases | ||||
| Seok-Won Kim 1, T Ishii 2, Shujiro Takeno 2, Yuki Kado 2, Yuya Tamai 2, Takeshi Akiyama 2, Eric Yu 2, Sven Demiya 2 (rwesheorj 1-2) | ||||
| 1,2) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan | ||||
| ISPOR 2021 Conference |
||||
| , Conference, Poster, Presentation | ||||
| , Japan | ||||
| Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/111047 | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19 | 2021 | English | , Database Study | |
| COVID-19 patient severities in Japanese EMR | ||||
| Masafumi Okada 1, Shingo Wada 1, Masaaki Isshiki 2, Sadako Utsunomiya 2, Takeshi Akiyama 1, Kenji Hamada 1, Sven Demiya 1 (rwesheorj 1) | ||||
| 1,2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan | ||||
| ISPOR 2021 Conference |
||||
| , Conference, Poster, Presentation | ||||
| , Japan | ||||
| Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/111009 | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19 | 2021 | English | , Database Study | |
| Understanding the COVID Impact on Healthcare System in Canada | ||||
| Juejing Ling, Scott Shi, Marc Lapierre, HuijuanYang, Brad Millson | ||||
| Juejing Ling IQVIA, Scott Shi IQVIA, Marc Lapierre IQVIA, HuijuanYang IQVIA, Brad Millson IQVIA | ||||
| 2021 CADTH Symposium Confrence, November 2, 3 and 4, 2021 |
||||
| , Poster | ||||
| , Canada | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19 | 2021 | English | , Clinical setting: Primary care, Economic evaluation | |
| Prescribing patterns among in-person vs virtual primary care visits pre-and post-COVID-19 in Ontario, Canada | ||||
| Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A | ||||
| Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A - all IQVIA authors | ||||
| CAPT 2021 Confrence, October 25-27, 2021 |
||||
| , Poster | ||||
| , Canada | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19 | 2021 | English | , Clinical setting: Primary care, Public Health, Survey research | |
| The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan | ||||
| Tomotaka Sobue 1 2, Haruhisa Fukuda 3, Tetsuya Matsumoto 4, Bennett Lee 5, Shuhei Ito 5*, Satoshi Iwata 6 (rwesheorj A) | ||||
| 1) Division of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan 2) Keio University School of Medicine, Tokyo, Japan 3) Department of Health Care Administration and Management, Kyushu University, Fukuoka, Japan 4) Department of Infectious Diseases, International University of Health and Welfare, Narita, Japan 5) Vaccine Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 6) Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan | ||||
| PLOS One |
||||
| , Article | ||||
| , Japan | ||||
| Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256379 | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19, Immunology and Vaccination | 2021 | English | , Database Study, Literature Review | |
| Who owns patient data? The answer is not that simple | ||||
| Alison Bourke, Georgina Bourke | ||||
| Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology. Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI. | ||||
| BJMOpinion August 6, 2020 |
||||
| , Article | ||||
| , UK, USA | ||||
| Abstract: https://blogs.bmj.com/bmj/2020/08/06/who-owns-patient-data-the-answer-is-not-that-simple/ | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19, Health policy | 2020 | English | , Market impact | |
| Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities | ||||
| Matthew W. Reynolds, Jennifer B Christian, Christina D Mack, Marni Hall and Nancy A Dreyer | ||||
| Matthew W. Reynolds, PhD, FISPE Vice President, Real World Evidence, IQVIA Christina Mack, PhD, MSPH Vice President, Epidemiology and Clinical Evidence, IQVIA Adjunct Faculty, UNC-Chapel Hill Marni Hall, PhD, MPH Vice President of Clinical Evidence, IQVIA Nancy Dreyer, PhD, FISPE Chief Scientific Officer and Senior Vice President, IQVIA Jennifer B. Christian, PharmD, MPH, PhD, FISPE | ||||
| Precision Medicine 2020; 6 (2), June |
||||
| , Article | ||||
| , USA | ||||
| Abstract: https://www.thejournalofprecisionmedicine.com/leveraging-real-world-data-for-covid-19-research-challenges-and-opportunities/ | ||||
| Condition | Year | Language | Analysis type | |
| , COVID-19 | 2020 | English | , Data linkage, Observational study, Population Based Study, Real World Data, Real World Evidence | |